The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.

Rituxan (rituximab) is not safe to receive while pregnant or breastfeeding. Certain factors, including fetal harm, may determine whether you should receive the drug during this time. If you may be ...

It looks increasingly likely that Roche’s cancer blockbuster Rituxan (rituximab) will face competition from a cheaper biosimilar in the coming months after backing from an FDA expert committee.

FDA grants traditional approval for Calquence with bendamustine and Rituxan for untreated MCL patients ineligible for autologous HSCT. Calquence also approved as a single-agent treatment for ...

Rituximab, a monoclonal antibody directed against the CD20 molecule found on pre-B cells and mature B cells (but not on plasma cells), was introduced in the late 1990s for the treatment of non ...

In January, the Swiss drug manufacturer Roche announced a €190 million ($175 million) investment to manufacture a device that enables the subcutaneous injection of biologics, notably its ...